This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Mar;7(3):e158.

doi: 10.1016/S2352-3018(20)30028-X.

Changes in inflammatory biomarkers in SWORD-1 and SWORD-2 studies

Sergio Serrano-Villar¹, Santiago Moreno²

Affiliations

Affiliations

¹ Hospital Universitario Ramón y Cajal, Madrid 28034, Spain. Electronic address: sergio.serrano@salud.madrid.org.
² Hospital Universitario Ramón y Cajal, Madrid 28034, Spain.

PMID: 32142710
DOI: 10.1016/S2352-3018(20)30028-X

Comment

Changes in inflammatory biomarkers in SWORD-1 and SWORD-2 studies

Sergio Serrano-Villar et al. Lancet HIV. 2020 Mar.

. 2020 Mar;7(3):e158.

doi: 10.1016/S2352-3018(20)30028-X.

Authors

Sergio Serrano-Villar¹, Santiago Moreno²

Affiliations

¹ Hospital Universitario Ramón y Cajal, Madrid 28034, Spain. Electronic address: sergio.serrano@salud.madrid.org.
² Hospital Universitario Ramón y Cajal, Madrid 28034, Spain.

PMID: 32142710
DOI: 10.1016/S2352-3018(20)30028-X

No abstract available

PubMed Disclaimer

Comment in

Changes in inflammatory biomarkers in SWORD-1 and SWORD-2 studies - Authors' reply.
Kahl LP. Kahl LP. Lancet HIV. 2020 Mar;7(3):e158-e159. doi: 10.1016/S2352-3018(20)30026-6. Lancet HIV. 2020. PMID: 32142711 No abstract available.

Comment on

Efficacy and safety of dolutegravir-rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies.
Aboud M, Orkin C, Podzamczer D, Bogner JR, Baker D, Khuong-Josses MA, Parks D, Angelis K, Kahl LP, Blair EA, Adkison K, Underwood M, Matthews JE, Wynne B, Vandermeulen K, Gartland M, Smith K. Aboud M, et al. Lancet HIV. 2019 Sep;6(9):e576-e587. doi: 10.1016/S2352-3018(19)30149-3. Epub 2019 Jul 12. Lancet HIV. 2019. PMID: 31307948 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information